ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Computerized Decision Support System for Antibiotic Treatment

This study has been completed.

Sponsors and Collaborators: Rabin Medical Center
Eu Fifth Framework IST
Information provided by: Rabin Medical Center
ClinicalTrials.gov Identifier: NCT00233376
  Purpose

We developed a computerized decision support system for prescription of antibiotics to inpatients. The purpose of the study is to assess the performance of the system in different wards, in three different hospitals, in three countries.


Condition Intervention Phase
Community-Acquired Infection
Cross Infection
Procedure: Access to an antibiotic decision support system
Behavioral: Distribution of local antibiotic guidelines
Phase III

MedlinePlus related topics:   Antibiotics   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   Improving Empirical Antibiotic Treatment Using TREAT,a Computerized Decision Support System. Cluster Randomized Trial

Further study details as provided by Rabin Medical Center:

Primary Outcome Measures:
  • Appropriate antibiotic treatment

Secondary Outcome Measures:
  • Overall 30-day mortality
  • Durations of fever
  • Duration of hospital stay
  • Antibiotic use
  • Antibiotic costs
  • Adverse events

Estimated Enrollment:   1500
Study Start Date:   May 2004
Estimated Study Completion Date:   November 2004

Detailed Description:

Antibiotic treatment for suspected moderate to severe bacterial infections is usually initiated empirically, prior to identification of the causative pathogen. Appropriate treatment, that is matching in-vitro susceptibilities of subsequently isolated pathogens, reduces the overall fatality rate of severe infections with adjusted odds ratios varying between 1.6 and 6.9. In the same studies, 20-50% of patients were given inappropriate empirical antibiotic treatment.

We developed a computerized decision support system (TREAT) based on a causal probabilistic network to improve antibiotic treatment of inpatients. The aims of the system were to improve the rate of appropriate antibiotic treatment, thereby reducing mortality, and to route antibiotic use towards ecologically economical antibiotics as determined by local resistance profiles. The system can be calibrated to different locations.

The TREAT system was tested in a multi-center observational cohort study. The study proved the system safe and effective. TREAT prescribed appropriate antibiotic treatment to 70% of patients, 58% of whom were treated appropriately by physicians. TREAT used a narrow antibiotic formulary and at lower costs, mainly lowering costs assigned by the model to future resistance. The system performed well in three different countries (Israel, Italy and Germany).

We then proceeded to assess the effect of TREAT on the management of inpatients in these sites in a cluster randomized controlled trial. We used wards as the unit of randomization to avoid contamination through education of users by the system, and to benefit from the interaction of TREAT with the ward as a whole.

Comparison: the TREAT system was installed in intervention wards and its use was offered to physicians at the time of empirical antibiotic treatment. Physicians were asked to inspect TREAT’s result interface. The final choice of antibiotic treatment was theirs. Control wards had no access to the system. We assessed outcomes in intervention vs. control wards with regard to patient outcomes, appropriateness of antibiotic treatment and antibiotic costs.

  Eligibility
Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Patients from whom blood cultures were drawn.
  • Patients prescribed antibiotics (not for prophylaxis).
  • Patients fulfilling sepsis diagnostic criteria.
  • Patients with a focus of infection.
  • Patients with shock compatible with septic shock.
  • Patients with febrile neutropenia

Exclusion Criteria:

  • HIV positive patients with a current (suspected or identified) opportunistic disease and/or AIDS defining illness currently or within the past six months
  • Organ or bone marrow transplant recipients
  • Children <18 years; suspected travel infections or tuberculosis
  • Pregnant women
  • Re-entries
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00233376

Locations
Germany
Department of Clinical Microbiology and Hospital Hygeine, Freiburg University Hospital    
      Freiburg, Germany
Israel
Rabin Medical Center; Beilinson Campus    
      Petah Tikva, Israel, 49100
Italy
Department of Infectious Diseases, Gemelli Hospital in Rome    
      Rome, Italy

Sponsors and Collaborators
Rabin Medical Center
Eu Fifth Framework IST

Investigators
Principal Investigator:     Leonard Leibovici, M.D.     Rabin Medical Center, Beilinson Campus    
Study Chair:     Steen Andreassen, PhD     Center for Model-based Medical Decision Support, Aalborg University    
  More Information


Project web site  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   IST-1999-11459, Fifth framework IST-1999-11459
First Received:   October 4, 2005
Last Updated:   July 17, 2006
ClinicalTrials.gov Identifier:   NCT00233376
Health Authority:   Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Rabin Medical Center:
Decision support system  
Causal probabilistic network  
Antibiotics  
Antibiotic resistance
Community-acquired infections
Cross-infections

Study placed in the following topic categories:
Community-Acquired Infections
Cross Infection

Additional relevant MeSH terms:
Communicable Diseases
Infection

ClinicalTrials.gov processed this record on October 03, 2008




Links to all studies - primarily for crawlers